BILAG Categories for Hematological Manifestations of SLE

Purpose: To categorize hematological findings in a patient with systemic lupus erythematosus (SLE) being evaluated with the BILAG index.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with SLE?

Yes

White blood cell count

Absolute lymphocyte count

per µL

Platelet count

Hemoglobin

Does the patient have?

• circulating lupus anticoagulant?

Yes

• a past history of hematological problems?

Yes

Hemolytic anemia

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Category of hematological findings

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
Laboratory Tests
Other Testing
- Clinical Features of Acute Lupus Pneumonitis
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Systemic Lupus Erythematosus (SLE) | Moyamoya Syndrome
Differential Diagnosis And Mimics, Red Flags

Therapy

Pharmacogenetics
Drug Interactions
- SELENA Flare Tool
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Prevention
Interventional Radiology

Monitoring

Drug Levels
- SELENA Flare Tool
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Disease Progression
Complication Detection
Comorbid Conditions

Patient Concerns

Quality Of Life
Psychological Response

Specialty

Immunology/Rheumatology

Objective

severity
prognosis
stage
differential diagnosis and mimics
red flags
disease progression
prevention

ICD-10

I50.1 - Left ventricular failure
M32 - Systemic lupus erythematosus

Info

Purpose: To categorize hematological findings in a patient with systemic lupus erythematosus (SLE) being evaluated with the BILAG index.

Specialty: Immunology/Rheumatology

Objective: severity, prognosis, stage, differential diagnosis and mimics, red flags, disease progression, prevention

ICD-10: I50.1, M32,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path